IL2 and atherosclerosis: In Dinh et al 2012, the data gathered about IL‐2 were shown to demonstrate that the IL‐2 complex which comprises IL‐2 and anti‐IL‐2 monoclonal antibody (mAb)(JES6‐1) selectively expands Treg cells up to six folds and effectively inhibits the development and progression of atherosclerosis in ApoE ‐/‐ mice significantly attenuates ventricular remodelling, resulting in reduced infarct size and improved left ventricular (LV) function.27